“Health Tech Corporation” (“HTC”) purchased pharmaceutical plant “Akrikhin”- one of the largest in Russia Cost of the deal is USD40 million. “HTC” proposes to arrange BAD production at “Akrikhin”.
“HTC” to be engaged in production of biologically active additives (BAD) in Russia
